Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

European Society of Surgical Oncology's strategy for clinical research: Paving the way for a culture of research in cancer surgery.

Evrard S, van de Velde C, Noordhoek I, Caballero C, Ceelen W, Polom K, Kolacinska A, Allum W, D'Ugo D, Malik HZ, Rubio IT, Wyld L, Leidenius M, Rivoire M, Zoras O, Polkowski W, Poston GJ, Audisio RA, Kovacs T, González-Moreno S; on the European Society of Surgical Oncology.

Eur J Surg Oncol. 2019 May 5. pii: S0748-7983(19)30440-8. doi: 10.1016/j.ejso.2019.05.004. [Epub ahead of print] Review.

PMID:
31085024
2.

Multicentre validation of a clinical prognostic score integrating the systemic inflammatory response to the host for patients treated with curative-intent for colorectal liver metastases: The Liverpool score.

Dupré A, Berhane S, Chan AWH, Rivoire M, Chong CCN, Lai PBS, Cucchetti A, Poston GJ, Malik HZ, Johnson PJ.

Eur J Surg Oncol. 2019 Jun;45(6):999-1004. doi: 10.1016/j.ejso.2019.02.022. Epub 2019 Feb 21.

PMID:
30827803
3.

Preoperative Leucocyte-Based Inflammatory Scores in Patients with Colorectal Liver Metastases: Can We Count on Them?

Dupré A, Jones RP, Diaz-Nieto R, Fenwick SW, Poston GJ, Malik HZ.

World J Surg. 2019 May;43(5):1351-1359. doi: 10.1007/s00268-019-04914-2.

PMID:
30673814
4.

Reshaping the critical role of surgeons in oncology research.

Jones RP, Are C, Hugh TJ, Grünhagen DJ, Xu J, Balch CM, Poston GJ.

Nat Rev Clin Oncol. 2019 May;16(5):327-332. doi: 10.1038/s41571-018-0149-1. Review.

PMID:
30617343
5.

Changing outlook for colorectal liver metastasis resection in the elderly.

Tufo A, Dunne DF, Manu N, Lacasia C, Jones L, de Liguori Carino N, Malik HZ, Poston GJ, Fenwick SW.

Eur J Surg Oncol. 2019 Apr;45(4):635-643. doi: 10.1016/j.ejso.2018.11.024. Epub 2018 Dec 4.

PMID:
30553630
6.

Clinical outcome after resection of early-stage hilar cholangiocarcinoma.

Stremitzer S, Jones RP, Quinn LM, Fenwick SW, Diaz-Nieto R, Poston GJ, Malik HZ.

Eur J Surg Oncol. 2019 Feb;45(2):213-217. doi: 10.1016/j.ejso.2018.09.008. Epub 2018 Oct 16.

PMID:
30360988
7.

Impact of centralization of services on outcomes in a rare tumour: Retroperitoneal sarcomas.

Kalaiselvan R, Malik AK, Rao R, Wong K, Ali N, Griffin M, Chandrasekar CR, Fenwick SF, Poston GJ, Malik H.

Eur J Surg Oncol. 2019 Feb;45(2):249-253. doi: 10.1016/j.ejso.2018.06.032. Epub 2018 Jul 10.

PMID:
30082178
8.

Optimal perioperative care in peri-hilar cholangiocarcinoma resection.

Quinn LM, Dunne DFJ, Jones RP, Poston GJ, Malik HZ, Fenwick SW.

Eur Surg. 2018;50(3):93-99. doi: 10.1007/s10353-018-0529-x. Epub 2018 May 4.

9.

Hepatectomy for octogenarians with colorectal liver metastasis in the era of enhanced recovery.

Tufo A, Dunne DFJ, Manu N, Joshi H, Lacasia C, Jones L, Malik HZ, Poston GJ, Fenwick SW.

Eur J Surg Oncol. 2018 Jul;44(7):1040-1047. doi: 10.1016/j.ejso.2018.01.089. Epub 2018 Feb 6.

PMID:
29456045
10.

Unresectable Colorectal Liver Metastases: When Definitions Matter to Appropriately Assess Extreme Liver Resection Techniques.

Gagnière J, Poston GJ, Boerner T, Le Roy B, Dupré A.

Ann Surg. 2018 Dec;268(6):e82-e83. doi: 10.1097/SLA.0000000000002677. No abstract available.

PMID:
29342016
11.

Validation of clinical prognostic scores for patients treated with curative-intent for recurrent colorectal liver metastases.

Dupré A, Rehman A, Jones RP, Parker A, Diaz-Nieto R, Fenwick SW, Poston GJ, Malik HZ.

J Surg Oncol. 2018 May;117(6):1330-1336. doi: 10.1002/jso.24959. Epub 2018 Jan 8.

PMID:
29315600
12.

Re: E Morris, T Treasure, Cancer Epidemiology, 49 (2017) 152-155.

Fenwick SW, Poston GJ, Cameron IC, Huguet E, Welsh FK.

Cancer Epidemiol. 2018 Feb;52:158-159. doi: 10.1016/j.canep.2017.12.009. Epub 2018 Jan 3. No abstract available.

PMID:
29306570
13.

Influence of the primary tumour location in patients undergoing surgery for colorectal liver metastases.

Dupré A, Malik HZ, Jones RP, Diaz-Nieto R, Fenwick SW, Poston GJ.

Eur J Surg Oncol. 2018 Jan;44(1):80-86. doi: 10.1016/j.ejso.2017.10.218. Epub 2017 Nov 21.

PMID:
29183640
14.

Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.

Dupré A, Jones RP, Diaz-Nieto R, Fenwick SW, Poston GJ, Malik HZ.

Eur J Surg Oncol. 2017 Oct;43(10):1901-1907. doi: 10.1016/j.ejso.2017.08.008. Epub 2017 Aug 26.

PMID:
28888801
15.

RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases.

Brudvik KW, Jones RP, Giuliante F, Shindoh J, Passot G, Chung MH, Song J, Li L, Dagenborg VJ, Fretland ÅA, Røsok B, De Rose AM, Ardito F, Edwin B, Panettieri E, Larocca LM, Yamashita S, Conrad C, Aloia TA, Poston GJ, Bjørnbeth BA, Vauthey JN.

Ann Surg. 2019 Jan;269(1):120-126. doi: 10.1097/SLA.0000000000002319.

PMID:
28549012
16.

Precision surgery for colorectal liver metastases: Opportunities and challenges of omics-based decision making.

Jones RP, Brudvik KW, Franklin JM, Poston GJ.

Eur J Surg Oncol. 2017 May;43(5):875-883. doi: 10.1016/j.ejso.2017.02.014. Epub 2017 Mar 6. Review.

PMID:
28302330
17.

Colorectal Liver Metastases: A Critical Review of State of the Art.

Jones RP, Kokudo N, Folprecht G, Mise Y, Unno M, Malik HZ, Fenwick SW, Poston GJ.

Liver Cancer. 2016 Nov;6(1):66-71. Epub 2016 Nov 29. Review.

18.

Resection of Liver Metastases in Colorectal Cancer in the Era of Expanding Systemic Therapy.

Jones RP, Poston GJ.

Annu Rev Med. 2017 Jan 14;68:183-196. doi: 10.1146/annurev-med-062415-093510. Epub 2016 Sep 28. Review.

PMID:
27686016
19.

PARAGON II - A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer.

Jones RP, Malik HZ, Fenwick SW, Terlizzo M, O'Grady E, Stremitzer S, Gruenberger T, Rees M, Plant G, Figueras J, Albiol M, Adam R, Awad S, Poston GJ.

Eur J Surg Oncol. 2016 Dec;42(12):1866-1872. doi: 10.1016/j.ejso.2016.07.142. Epub 2016 Aug 10.

20.

Training a new generation of surgeons worldwide who are also oncologists.

Balch CM, Poston GJ, Coit D, Audisio R.

Chin Clin Oncol. 2016 Aug;5(4):58. doi: 10.21037/cco.2016.07.02. No abstract available.

21.

Objective assessment of trainee operative experience in a tertiary hepatobiliary unit.

Joshi HM, Alabraba E, Tufo A, Zone A, Ghaneh P, Fenwick SW, Poston GJ, Malik HZ.

Eur J Surg Oncol. 2016 Oct;42(10):1548-51. doi: 10.1016/j.ejso.2016.07.139. Epub 2016 Aug 10.

PMID:
27546012
22.

Adherence to early mobilisation: Key for successful enhanced recovery after liver resection.

Yip VS, Dunne DF, Samuels S, Tan CY, Lacasia C, Tang J, Burston C, Malik HZ, Poston GJ, Fenwick SW.

Eur J Surg Oncol. 2016 Oct;42(10):1561-7. doi: 10.1016/j.ejso.2016.07.015. Epub 2016 Aug 3.

PMID:
27528466
23.

The risk of malignancy in ultrasound detected gallbladder polyps: A systematic review.

Elmasry M, Lindop D, Dunne DF, Malik H, Poston GJ, Fenwick SW.

Int J Surg. 2016 Sep;33 Pt A:28-35. doi: 10.1016/j.ijsu.2016.07.061. Epub 2016 Jul 25. Review.

24.

Training a new generation of surgical oncologists worldwide.

Balch CM, Poston GJ.

Lancet Oncol. 2016 Jun;17(6):700-701. doi: 10.1016/S1470-2045(16)30153-X. No abstract available.

PMID:
27299262
25.

Common variables in European pancreatic cancer registries: The introduction of the EURECCA pancreatic cancer project.

de Leede EM, Sibinga Mulder BG, Bastiaannet E, Poston GJ, Sahora K, Van Eycken E, Valerianova Z, Mortensen MB, Dralle H, Primic-Žakelj M, Borràs JM, Gasslander T, Ryzhov A, Lemmens VE, Mieog JS, Boelens PG, van de Velde CJ, Bonsing BA.

Eur J Surg Oncol. 2016 Sep;42(9):1414-9. doi: 10.1016/j.ejso.2016.03.011. Epub 2016 Mar 28.

PMID:
27061790
26.

Randomized clinical trial of prehabilitation before planned liver resection.

Dunne DF, Jack S, Jones RP, Jones L, Lythgoe DT, Malik HZ, Poston GJ, Palmer DH, Fenwick SW.

Br J Surg. 2016 Apr;103(5):504-12. doi: 10.1002/bjs.10096. Epub 2016 Feb 11.

PMID:
26864728
27.

Decision Making Around Optimal Management of Liver-Limited Metastatic Colorectal Cancer.

Jones RP, Poston GJ.

Ann Surg Oncol. 2016 Feb;23(2):353-4. doi: 10.1245/s10434-015-5002-5. Epub 2015 Dec 2. No abstract available.

PMID:
26631387
28.

Rectal cancer with synchronous liver metastases: Do we have a clear direction?

Pathak S, Nunes QM, Daniels IR, Smart NJ, Poston GJ, Påhlman L.

Eur J Surg Oncol. 2015 Dec;41(12):1570-7. doi: 10.1016/j.ejso.2015.09.013. Epub 2015 Oct 13. Review.

PMID:
26497090
29.

Global cancer surgery: The Lancet Oncology review.

Poston GJ.

Eur J Surg Oncol. 2015 Dec;41(12):1559-61. doi: 10.1016/j.ejso.2015.09.004. Epub 2015 Sep 18. No abstract available.

PMID:
26412556
30.

Prognostic molecular markers in resected extrahepatic biliary tract cancers; a systematic review and meta-analysis of immunohistochemically detected biomarkers.

Jones RP, Bird NT, Smith RA, Palmer DH, Fenwick SW, Poston GJ, Malik HZ.

Biomark Med. 2015;9(8):763-75. doi: 10.2217/BMM.15.48. Epub 2015 Jul 30. Review.

PMID:
26223884
31.

Variation in Cardiac Screening and Management of Carcinoid Heart Disease in the UK and Republic of Ireland.

Dobson R, Valle JW, Burgess MI, Poston GJ, Cuthbertson DJ.

Clin Oncol (R Coll Radiol). 2015 Dec;27(12):741-6. doi: 10.1016/j.clon.2015.06.016. Epub 2015 Jul 11.

PMID:
26170123
32.

Reply to J.N. Primrose et al and C.-H. Köhne.

Nordlinger BM, Poston GJ, Goldberg RM.

J Clin Oncol. 2015 Jul 20;33(21):2408-9. doi: 10.1200/JCO.2014.60.4751. Epub 2015 Jun 1. No abstract available.

PMID:
26033799
33.

Blood cultures in acute surgical admissions.

Dunne DF, McDonald R, Ratnayake R, Malik HZ, Ward R, Poston GJ, Fenwick SW.

Ann R Coll Surg Engl. 2015 Jan;97(1):27-31. doi: 10.1308/003588414X14055925059110.

34.

Clinical trials of interventional oncology-moving from efficacy to outcomes.

Franklin JM, Gebski V, Poston GJ, Sharma RA.

Nat Rev Clin Oncol. 2015 Feb;12(2):93-104. doi: 10.1038/nrclinonc.2014.199. Epub 2014 Dec 9. Review.

PMID:
25488395
35.

Should the results of the new EPOC trial change practice in the management of patients with resectable metastatic colorectal cancer confined to the liver?

Nordlinger B, Poston GJ, Goldberg RM.

J Clin Oncol. 2015 Jan 20;33(3):241-3. doi: 10.1200/JCO.2014.58.3989. Epub 2014 Nov 17. No abstract available.

PMID:
25403221
36.

The evolution of cancer surgery and future perspectives.

Wyld L, Audisio RA, Poston GJ.

Nat Rev Clin Oncol. 2015 Feb;12(2):115-24. doi: 10.1038/nrclinonc.2014.191. Epub 2014 Nov 11. Review.

PMID:
25384943
37.

A systematic review of the role of hepatectomy in the management of metastatic renal cell carcinoma.

Grimes NG, Devlin JM, Dunne DF, Jones RP, Poston GJ, Fenwick SW, Malik HZ.

Eur J Surg Oncol. 2014 Dec;40(12):1622-8. doi: 10.1016/j.ejso.2014.08.472. Epub 2014 Aug 27. Review.

PMID:
25228053
38.

Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality.

Dobson R, Burgess MI, Valle JW, Pritchard DM, Vora J, Wong C, Chadwick C, Keevi B, Adaway J, Hofmann U, Poston GJ, Cuthbertson DJ.

Br J Cancer. 2014 Oct 28;111(9):1703-9. doi: 10.1038/bjc.2014.468. Epub 2014 Sep 11.

39.

Cardiopulmonary exercise testing before liver surgery.

Dunne DF, Jones RP, Lythgoe DT, Pilkington FJ, Palmer DH, Malik HZ, Poston GJ, Lacasia C, Jack S, Fenwick SW.

J Surg Oncol. 2014 Sep;110(4):439-44. doi: 10.1002/jso.23670. Epub 2014 Jun 4.

PMID:
24894657
40.

Enhanced recovery in the resection of colorectal liver metastases.

Dunne DF, Yip VS, Jones RP, McChesney EA, Lythgoe DT, Psarelli EE, Jones L, Lacasia-Purroy C, Malik HZ, Poston GJ, Fenwick SW.

J Surg Oncol. 2014 Aug;110(2):197-202. doi: 10.1002/jso.23616. Epub 2014 Apr 8.

PMID:
24715651
41.

Defined criteria for resectability improves rates of secondary resection after systemic therapy for liver limited metastatic colorectal cancer.

Jones RP, Hamann S, Malik HZ, Fenwick SW, Poston GJ, Folprecht G.

Eur J Cancer. 2014 Jun;50(9):1590-601. doi: 10.1016/j.ejca.2014.02.024. Epub 2014 Mar 21. Review.

PMID:
24661798
42.

When should a liver resection be performed in patients with liver metastases from neuroendocrine tumours? A systematic review with practice recommendations.

Lesurtel M, Nagorney DM, Mazzaferro V, Jensen RT, Poston GJ.

HPB (Oxford). 2015 Jan;17(1):17-22. doi: 10.1111/hpb.12225. Epub 2014 Mar 17. Review.

43.

Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience.

Stättner S, Primavesi F, Yip VS, Jones RP, Öfner D, Malik HZ, Fenwick SW, Poston GJ.

Surg Today. 2015 Apr;45(4):407-15. doi: 10.1007/s00595-014-0879-3. Epub 2014 Mar 16. Review.

PMID:
24633931
44.

Controversies in the oncosurgical management of liver limited stage IV colorectal cancer.

Jones RP, Stättner S, Sutton P, Dunne DF, McWhirter D, Fenwick SW, Malik HZ, Poston GJ.

Surg Oncol. 2014 Jun;23(2):53-60. doi: 10.1016/j.suronc.2014.02.002. Epub 2014 Mar 2. Review.

PMID:
24631118
45.

Surgical management of colorectal liver metastases: a European perspective.

Dunne DF, Jones RP, Malik HZ, Fenwick SW, Poston GJ.

Hepat Oncol. 2014 Jan;1(1):121-133. doi: 10.2217/hep.13.3. Epub 2013 Dec 20. Review.

46.

The Liverpool uveal melanoma liver metastases pathway: outcome following liver resection.

Gomez D, Wetherill C, Cheong J, Jones L, Marshall E, Damato B, Coupland SE, Ghaneh P, Poston GJ, Malik HZ, Fenwick SW.

J Surg Oncol. 2014 May;109(6):542-7. doi: 10.1002/jso.23535. Epub 2013 Dec 19.

PMID:
24357463
47.

Optimal imaging sequence for staging in colorectal liver metastases: analysis of three hypothetical imaging strategies.

Yip VS, Collins B, Dunne DF, Koay MY, Tang JM, Wieshmann H, Fenwick SW, Poston GJ, Malik HZ.

Eur J Cancer. 2014 Mar;50(5):937-43. doi: 10.1016/j.ejca.2013.11.025. Epub 2013 Dec 11.

PMID:
24332574
48.

FDG-PET-CT is effective in selecting patients with poor long term survivals for colorectal liver metastases.

Yip VS, Poston GJ, Fenwick SW, Wieshmann H, Athwal T, Malik HZ.

Eur J Surg Oncol. 2014 Aug;40(8):995-9. doi: 10.1016/j.ejso.2013.10.026. Epub 2013 Nov 15.

PMID:
24290370
49.

Management of incidental and suspicious gallbladder cancer: focus on early referral to a tertiary centre.

Yip VS, Gomez D, Brown S, Byrne C, White D, Fenwick SW, Poston GJ, Malik HZ.

HPB (Oxford). 2014 Jul;16(7):641-7. doi: 10.1111/hpb.12189. Epub 2013 Nov 27.

50.

Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma.

Gomez D, Patel PB, Lacasia-Purroy C, Byrne C, Sturgess RP, Palmer D, Fenwick S, Poston GJ, Malik HZ.

Eur J Surg Oncol. 2014 Jan;40(1):77-84. doi: 10.1016/j.ejso.2013.10.009. Epub 2013 Oct 23.

PMID:
24262111

Supplemental Content

Loading ...
Support Center